Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Arteriosclerosis obliterans]

M Kitatani1, H Mabuchi, K Ueda

  • 1Second Department of Internal Medicine, Kanazawa University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical significance of measuring soluble LR11, a circulating marker of atherosclerosis and HbA1c in familial hypercholesterolemia.

Clinical biochemistry·2014
Same author

Association of angiopoietin-like protein 3 with hepatic triglyceride lipase and lipoprotein lipase activities in human plasma.

Annals of clinical biochemistry·2010
Same author

Real-time detection of individual atoms falling through a high-finesse optical cavity.

Optics letters·2009
Same author

Atom galleries for whispering atoms: binding atoms in stable orbits around an optical resonator.

Optics letters·2009
Same author

Postprandial triglyceridaemia in men with impaired fasting glucose, impaired glucose tolerance and diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2008
Same author

A novel method for measuring human lipoprotein lipase and hepatic lipase activities in postheparin plasma.

Journal of lipid research·2008
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Arteriosclerosis obliterans (ASO) is a significant health issue for elderly Japanese individuals. Recent advancements offer improved diagnostic and treatment options, including minimally invasive procedures and LDL-apheresis.

Area of Science:

  • Vascular Medicine
  • Geriatric Health
  • Cardiovascular Research

Context:

  • Arteriosclerosis obliterans (ASO) presents a growing health challenge, particularly among the elderly population in Japan.
  • ASO is a systemic condition often coexisting with other atherosclerotic diseases, impacting cerebrovascular, coronary, and renal systems.
  • The comprehensive management of ASO requires consideration of the patient's overall health status and quality of life.

Purpose:

  • To review recent advancements in the diagnosis and treatment of Arteriosclerosis Obliterans (ASO).
  • To highlight the development of various medical and surgical therapeutic strategies for ASO.
  • To emphasize the importance of a holistic approach in managing ASO patients.

Summary:

  • Recent progress in ASO diagnosis and treatment is reviewed, focusing on innovative medical and surgical interventions.

Related Experiment Videos

  • Advanced treatments include atherectomy catheters, endovascular metallic stenting, laser angioplasty, and LDL-apheresis.
  • Effective ASO management necessitates a thorough evaluation of the patient's complete medical profile and quality of life.

    • Impact:

    • Improved diagnostic accuracy and therapeutic efficacy for Arteriosclerosis Obliterans.
    • Enhanced treatment options for elderly patients with ASO, potentially improving outcomes.
    • Greater consideration for patient quality of life in ASO treatment planning.